| abstract |
Disclosed is a pharmaceutical composition effective for the prevention and / or treatment of diseases such as arteriosclerotic diseases, hyperlipidemia or dyslipidemia, in which inhibition of cholesteryl ester transfer protein (CETP) is beneficial. A general formula (1): (In the formula, Y is a methylene group, A is a heterocyclic group which may be substituted, B is a heterocyclic group which may be substituted, and R 1 is substituted. Or a pharmacology thereof, which may be further substituted with an optionally substituted homocyclic group or the like, and R 2 is an optionally substituted amino group or the like. A pharmaceutical composition comprising a pharmaceutically acceptable derivative as an active ingredient. [Selection figure] None |